Skip to search formSkip to main contentSkip to account menu

DAS181

Known as: 273-666-Neuraminidase [273-Methionine] (Actinomyces viscosus Clone DAS181) Fusion Protein With 125-145-Preproamphiregulin (Human), DAS181-F02, Recombinant Cell-Surface Anchored Sialidase DAS181 
A recombinant sialidase fusion protein composed of a sialidase catalytic domain derived from Actinomyces viscosus, a constituent of the normal oral… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Recombinant Fusion Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory…
Abstract Background PIV infections are an important cause of morbidity and mortality in IC patients. DAS181, a sialidase fusion… 
2018
2018
1716. Results of the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
Abstract Results of the Respiratory Protection Effectiveness Clinical Trial (ResPECT) Background Respiratory protection (RP) for… 
2016
2016
Oral Ribavirin Treatment Failure for Severe Parainfluenza Type 1 Infection in a Patient with End Stage Interstitial Lung Disease Successfully Treated with DAS181
Parainfluenza virus (PIV) infections can cause serious respiratory infections and death in immunocompromised patients. No… 
2012
2012
DAS181 - a novel conjugated sialidase protein for the treatment of Influenza
2009
2009
Pandemic H1N1 2009 and Drug Resistant Influenza Viruses are Potently Inhibited by DAS181, a Sialidase Fusion Protein
2009
2009
DAS181 and H5N1 Virus Infection. Authors' reply
2008
2008
Use of DAS181 as a potential therapy for influenza
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)